{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:33:44Z","timestamp":1792431224767,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL134632"],"award-info":[{"award-number":["HL134632"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["H28-29"],"award-info":[{"award-number":["H28-29"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010486","name":"Teijin Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.chest.2020.06.078","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T11:15:20Z","timestamp":1596626120000},"page":"2632-2645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Acetazolamide for OSA and Central Sleep Apnea"],"prefix":"10.1016","volume":"158","author":[{"given":"Christopher N.","family":"Schmickl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane A.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy E.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Verbraecken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Javaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.chest.2020.06.078_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"9918","key":"10.1016\/j.chest.2020.06.078_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","article-title":"Adult obstructive sleep apnoea","volume":"383","author":"Jordan","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.chest.2020.06.078_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacc.2016.11.069","article-title":"Sleep apnea: types, mechanisms, and clinical cardiovascular consequences","volume":"69","author":"Javaheri","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.chest.2020.06.078_bib4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.chest.2020.06.078_bib5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.5664\/jcsm.7112","article-title":"Prevalence, associated clinical features, and impact on continuous positive airway pressure use of a low respiratory arousal threshold among male United States veterans with obstructive sleep apnea","volume":"14","author":"Zinchuk","year":"2018","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.chest.2020.06.078_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2015.07.038","article-title":"Long-term adherence to continuous positive airway pressure therapy in non-sleepy sleep apnea patients","volume":"17","author":"Campos-Rodriguez","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.chest.2020.06.078_bib7","first-page":"114","article-title":"Short-term CPAP adherence in obstructive sleep apnea: a big data analysis using real world data","volume":"59","author":"Cistulli","year":"2019"},{"issue":"5","key":"10.1016\/j.chest.2020.06.078_bib8","first-page":"CD003002","article-title":"Drug therapy for obstructive sleep apnoea in adults","volume":"31","author":"Mason","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.chest.2020.06.078_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.smrv.2019.04.009","article-title":"Efficacy of pharmacotherapy for OSA in adults: a systematic review and network meta-analysis","volume":"46","author":"Gaisl","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"8","key":"10.1016\/j.chest.2020.06.078_bib10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/sleep\/29.8.1036","article-title":"Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine","volume":"29","author":"Veasey","year":"2006","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.chest.2020.06.078_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1378\/chest.06.2287","article-title":"Central sleep apnea: pathophysiology and treatment","volume":"131","author":"Eckert","year":"2007","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.chest.2020.06.078_bib12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4187\/respcare.10551168","article-title":"What is central sleep apnea?","volume":"55","author":"Malhotra","year":"2010","journal-title":"Respir Care"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/resp.12927","article-title":"Pathogenesis of central and complex sleep apnoea","volume":"22","author":"Orr","year":"2017","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.chest.2020.06.078_bib14","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","article-title":"Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea","volume":"590","author":"Edwards","year":"2012","journal-title":"J\u00a0Physiol"},{"issue":"8","key":"10.1016\/j.chest.2020.06.078_bib15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1164\/rccm.201303-0448OC","article-title":"Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets","volume":"188","author":"Eckert","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2020.06.078_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40675-018-0121-8","article-title":"OSA endotypes: what are they and what are their potentialclinical implications?","volume":"4","author":"Schmickl","year":"2018","journal-title":"Curr Sleep Med Rep"},{"issue":"6","key":"10.1016\/j.chest.2020.06.078_bib17","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/09031936.98.12061242","article-title":"Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression","volume":"12","author":"Swenson","year":"1998","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib18","doi-asserted-by":"crossref","first-page":"e000557","DOI":"10.1136\/bmjresp-2020-000557","article-title":"Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence","volume":"7","author":"Schmickl","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"10","key":"10.1016\/j.chest.2020.06.078_bib19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/aje\/kwm189","article-title":"Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles","volume":"166","author":"Shrier","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5665\/sleep.1580","article-title":"The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses","volume":"35","author":"Aurora","year":"2012","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.chest.2020.06.078_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/ajrccm.158.3.9802019","article-title":"Pharmacologic treatment of sleep-disordered breathing","volume":"158","author":"Hudgel","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1753465816677006","article-title":"The effect of acetazolamide on sleep apnea at high altitude: a systematic review and meta-analysis","volume":"11","author":"Liu","year":"2017","journal-title":"Ther Adv Respir Dis"},{"issue":"3","key":"10.1016\/j.chest.2020.06.078_bib23","first-page":"349","article-title":"Acetazolamide therapy in patients with heart failure: a meta-analysis","volume":"8","author":"Wongboonsin","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.chest.2020.06.078_bib24","unstructured":"Owens RL, Malhotra A. Acetazolamide for sleep disordered breathing: a systematic review and meta-analysis of effects and side-effects. Paper presented as RAPID-Poster (A109) at: ATS Conference; May 1, 2019; Dallas, TX."},{"key":"10.1016\/j.chest.2020.06.078_bib25","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].","year":"2011"},{"key":"10.1016\/j.chest.2020.06.078_bib26","series-title":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]","article-title":"Handling Continuous Outcomes in Quantitative Synthesis. 2013 Jul 25","author":"Fu","year":"2008"},{"issue":"7414","key":"10.1016\/j.chest.2020.06.078_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.chest.2020.06.078_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2288-8-32","article-title":"The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study","volume":"8","author":"Friedrich","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"10.1016\/j.chest.2020.06.078_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/eurheartj\/eht540","article-title":"Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial","volume":"36","author":"Ulrich","year":"2015","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.chest.2020.06.078_bib30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1001\/jama.2012.94847","article-title":"Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial","volume":"308","author":"Latshang","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1378\/chest.11-0375","article-title":"Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial","volume":"141","author":"Nussbaumer-Ochsner","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.06.078_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.200507-1035OC","article-title":"Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study","volume":"173","author":"Javaheri","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1183\/09031936.03.00113102","article-title":"Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude","volume":"23","author":"Fischer","year":"2004","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2020.06.078_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/sleep\/11.5.463","article-title":"Role of protriptyline and acetazolamide in the sleep apnea\/hypopnea syndrome","volume":"11","author":"Whyte","year":"1988","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.chest.2020.06.078_bib35","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/arrd.1987.135.4.896","article-title":"Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide","volume":"135","author":"Hackett","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.chest.2020.06.078_bib36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cardfail.2014.01.007","article-title":"Acetazolamide and inhaled carbon dioxide reduce periodic breathing during exercise in patients with chronic heart failure","volume":"20","author":"Apostolo","year":"2014","journal-title":"J\u00a0Card Fail"},{"issue":"4","key":"10.1016\/j.chest.2020.06.078_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.wem.2011.07.002","article-title":"Improving sleep at altitude: a comparison of therapies","volume":"22","author":"Rodway","year":"2011","journal-title":"Wilderness Environ Med"},{"issue":"3","key":"10.1016\/j.chest.2020.06.078_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5664\/jcsm.6968","article-title":"Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: a randomized controlled trial","volume":"14","author":"Eskandari","year":"2018","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"11","key":"10.1016\/j.chest.2020.06.078_bib39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.amjcard.2011.01.060","article-title":"Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure","volume":"107","author":"Fontana","year":"2011","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2020.06.078_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1440-1819.1999.00551.x","article-title":"Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome","volume":"53","author":"Inoue","year":"1999","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1440-1819.1995.tb01858.x","article-title":"Effects of acetazolamide on the sleep apnea syndrome and its therapeutic mechanism","volume":"49","author":"Sakamoto","year":"1995","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/ajrccm.151.1.7812578","article-title":"Central apnea index decreases after prolonged treatment with acetazolamide","volume":"151","author":"DeBacker","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2020.06.078_bib43","first-page":"270","article-title":"Therapy and clinical symptoms in patients with obstructive sleep apnea in Japan [in Japanese]","volume":"30","author":"Chin","year":"1992","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.chest.2020.06.078_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/thx.43.2.113","article-title":"Effects of acetazolamide in patients with the sleep apnoea syndrome","volume":"43","author":"Tojima","year":"1988","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.chest.2020.06.078_bib45","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1001\/archinte.1982.00340230056012","article-title":"Central sleep apnea. Improvement with acetazolamide therapy","volume":"142","author":"White","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.chest.2020.06.078_bib46","first-page":"A3986","article-title":"Acetazolamide decreases susceptibility to hypocapnic central apnea in chronic sci","volume":"197","author":"Ginter","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2020.06.078_bib47","first-page":"A3903","article-title":"Acetazolamide stabilizes breathing in healthy older adults during NREM sleep","volume":"201","author":"Pranathiageswaran","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2020.06.078_bib48","first-page":"857","article-title":"Effects of acetazolamide in patients with obstructive sleep apnea syndrome and chronic heart failure","volume":"31","author":"Belyavskiy","year":"2010","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.chest.2020.06.078_bib49","first-page":"493","article-title":"Therapeutic effects of a carbonic anhydrase inhibitor (acetazolamide) on sleep apnea syndrome. Multicenter clinical investigation","volume":"9","author":"Inoue","year":"1987","journal-title":"Jpn J Neuropsychopharmacol"},{"issue":"24","key":"10.1016\/j.chest.2020.06.078_bib50","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197912133012406","article-title":"Effect of acetazolamide on hypoxemia during sleep at high altitude","volume":"301","author":"Sutton","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1378\/chest.14-0317","article-title":"Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude","volume":"147","author":"Caravita","year":"2015","journal-title":"Chest"},{"issue":"7414","key":"10.1016\/j.chest.2020.06.078_bib52","first-page":"177","article-title":"Effect of a single dose of acetazolamide on central apnea index in patients with central sleep apnea","volume":"16","author":"Verbraecken","year":"2005","journal-title":"Sleep-Wake Research in The Netherlands"},{"key":"10.1016\/j.chest.2020.06.078_bib53","series-title":"Effect of acetazolamide on central sleep apnea related to opium consumption. NCT02371473. ClinicalTrials.gov","year":"2015"},{"key":"10.1016\/j.chest.2020.06.078_bib54","series-title":"Predicting successful sleep apnea treatment with acetazolamide in heart failure patients. NCT01377987. ClinicalTrials.gov","year":"2011"},{"key":"10.1016\/j.chest.2020.06.078_bib55","series-title":"Buspirone as a potential treatment for recurrent central apnea. NCT00746954. ClinicalTrials.gov","year":"2008"},{"issue":"3","key":"10.1016\/j.chest.2020.06.078_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.18093\/0869-0189-2016-26-3-379-384","article-title":"Development of the optimal therapy for obstructive sleep apnea syndrome associated with pulmonary hypertension patients living at high altitude","volume":"26","author":"Myrzaakhmatova","year":"2016","journal-title":"Pulmonologiya"},{"issue":"4","key":"10.1016\/j.chest.2020.06.078_bib57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/HYPERTENSIONAHA.111.00707","article-title":"Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide","volume":"61","author":"Salvi","year":"2013","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.chest.2020.06.078_bib58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/thoraxjnl-2018-211959","article-title":"Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials","volume":"74","author":"Crook","year":"2019","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.chest.2020.06.078_bib59","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/rccm.201704-0672LE","article-title":"The Epworth Sleepiness Scale: minimum clinically important difference in obstructive sleep apnea","volume":"197","author":"Patel","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2020.06.078_bib60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.5664\/jcsm.2170","article-title":"The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Montesi","year":"2012","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.chest.2020.06.078_bib61","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1378\/chest.13-1115","article-title":"Effect of CPAP on blood pressure in patients with OSA\/hypopnea a systematic review and meta-analysis","volume":"145","author":"Fava","year":"2014","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2020.06.078_bib62","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.5665\/sleep.4814","article-title":"Increased carbonic anhydrase activity is associated with sleep apnea severity and related hypoxemia","volume":"38","author":"Wang","year":"2015","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.chest.2020.06.078_bib63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0703825","article-title":"In\u00a0vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature","volume":"132","author":"Pickkers","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.chest.2020.06.078_bib64","doi-asserted-by":"crossref","first-page":"H2068","DOI":"10.1152\/ajpheart.00525.2009","article-title":"Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation","volume":"297","author":"Aamand","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.chest.2020.06.078_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.01.015","article-title":"Carbonic anhydrase II does not exhibit Nitrite reductase or Nitrous Anhydrase Activity","volume":"117","author":"Andring","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.chest.2020.06.078_bib66","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1113\/JP275894","article-title":"Carbonic anhydrase is not a relevant nitrite reductase or nitrous anhydrase in the lung","volume":"597","author":"Pickerodt","year":"2019","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.chest.2020.06.078_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1513\/AnnalsATS.201306-201OC","article-title":"Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure","volume":"11","author":"Javaheri","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2020.06.078_bib68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5664\/jcsm.27497","article-title":"Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults","volume":"5","author":"Epstein","year":"2009","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"8","key":"10.1016\/j.chest.2020.06.078_bib69","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/sleep\/29.8.1031","article-title":"Practice parameters for the medical therapy of obstructive sleep apnea","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.chest.2020.06.078_bib70","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6: rating the\u00a0quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"7652","key":"10.1016\/j.chest.2020.06.078_bib71","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.chest.2020.06.078_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleep\/zsz186","article-title":"The physiological phenotype of obstructive sleep apnea differs between Caucasian and Chinese patients","volume":"42","author":"O\u2019Driscoll","year":"2019","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.chest.2020.06.078_bib73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.mjt.0000182359.63457.01","article-title":"Effects of the selective cyclooxygenase-2 inhibitor analgesic celecoxib on renal carbonic anhydrase enzyme activity: a randomized, controlled trial","volume":"13","author":"Alper","year":"2006","journal-title":"Am J Ther"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220319048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220319048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:52:52Z","timestamp":1777398772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220319048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0012369220319048"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.06.078","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetazolamide for OSA and Central Sleep Apnea","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.06.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}